{
    "organizations": [],
    "uuid": "31db8a3354410291fa7b661e2fdec9d6d3e1d4b0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-teva-launches-qvar-redihaler-inhal/brief-teva-launches-qvar-redihaler-inhalation-aerosol-in-u-s-idUSFWN1Q20U5",
    "ord_in_thread": 0,
    "title": "BRIEF-Teva Launches Qvar Redihaler Inhalation Aerosol In U.S.",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Teva Pharmaceutical Industries Ltd :\n* TEVA ANNOUNCES U.S. LAUNCH OF QVAR® REDIHALER™ (BECLOMETHASONE DIPROPIONATE HFA) INHALATION AEROSOL\n* WITH LAUNCH OF QVAR REDIHALER, TEVA IS DISCONTINUING SALES OF PREVIOUSLY AVAILABLE QVAR\n* QVAR REDIHALER WILL BE PRICED AT PARITY TO QVAR Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-12T21:18:00.000+02:00",
    "crawled": "2018-02-13T16:06:06.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "teva",
        "announces",
        "launch",
        "beclomethasone",
        "dipropionate",
        "hfa",
        "inhalation",
        "aerosol",
        "launch",
        "qvar",
        "redihaler",
        "teva",
        "discontinuing",
        "sale",
        "previously",
        "available",
        "qvar",
        "qvar",
        "redihaler",
        "priced",
        "parity",
        "qvar",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}